Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1980 1
1981 1
1982 5
1983 6
1984 3
1985 5
1986 4
1987 4
1988 4
1989 3
1990 3
1991 3
1992 5
1993 5
1994 2
1996 2
1997 1
1998 4
1999 2
2000 5
2001 5
2002 5
2003 5
2004 7
2005 5
2006 4
2007 4
2008 6
2009 3
2010 13
2011 6
2012 5
2013 6
2014 6
2015 1
2016 1
2017 6
2018 5
2019 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab by subcutaneous route.
Solal-Celigny P. Solal-Celigny P. Expert Rev Hematol. 2015 Apr;8(2):147-53. doi: 10.1586/17474086.2015.1024651. Expert Rev Hematol. 2015. PMID: 25749209 Review.
Follicular non-Hodgkin's lymphoma.
Hayashi D, Lee JC, Devenney-Cakir B, Zaim S, Ounadjela S, Solal-Céligny P, Juweid M, Guermazi A. Hayashi D, et al. Among authors: solal celigny p. Clin Radiol. 2010 May;65(5):408-20. doi: 10.1016/j.crad.2010.01.010. Epub 2010 Mar 15. Clin Radiol. 2010. PMID: 20380942 Review.
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
Brice P, Bastion Y, Lepage E, Brousse N, Haïoun C, Moreau P, Straetmans N, Tilly H, Tabah I, Solal-Céligny P. Brice P, et al. Among authors: solal celigny p. J Clin Oncol. 1997 Mar;15(3):1110-7. doi: 10.1200/JCO.1997.15.3.1110. J Clin Oncol. 1997. PMID: 9060552 Clinical Trial.
Prognosis of follicular lymphomas.
Solal-Celigny P. Solal-Celigny P. Clin Lymphoma. 2005 Jun;6(1):21-5. doi: 10.3816/clm.2005.n.022. Clin Lymphoma. 2005. PMID: 15989702 Review.
Intensive therapies in follicular non-Hodgkin lymphomas.
Hunault-Berger M, Ifrah N, Solal-Celigny P; Groupe Ouest-Est des Leucémies Aiguëe et des Maladies du Sang. Hunault-Berger M, et al. Among authors: solal celigny p. Blood. 2002 Aug 15;100(4):1141-52. Blood. 2002. PMID: 12149190 Free article. Review. No abstract available.
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Fischer L, Jiang L, Dürig J, Schmidt C, Stilgenbauer S, Bouabdallah K, Solal-Celigny P, Scholz CW, Feugier P, de Wit M, Trappe RU, Hallek M, Graeven U, Hänel M, Hoffmann M, Delwail V, Macro M, Greiner J, Giagounidis AAN, Dargel B, Durot E, Foussard C, Silkenstedt E, Weigert O, Pott C, Klapper W, Hiddemann W, Unterhalt M, Hoster E, Ribrag V, Dreyling M. Fischer L, et al. Among authors: solal celigny p. Leukemia. 2024 Jun;38(6):1307-1314. doi: 10.1038/s41375-024-02254-2. Epub 2024 Apr 27. Leukemia. 2024. PMID: 38678093 Free PMC article. Clinical Trial.
From the bench to the bedside: ways to improve rituximab efficacy.
Cartron G, Watier H, Golay J, Solal-Celigny P. Cartron G, et al. Among authors: solal celigny p. Blood. 2004 Nov 1;104(9):2635-42. doi: 10.1182/blood-2004-03-1110. Epub 2004 Jun 29. Blood. 2004. PMID: 15226177 Free article. Review.
154 results